PH-triggered therapeutical wound dressing

US11931477B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11931477-B2
Application numberUS-201917288452-A
CountryUS
Kind codeB2
Filing dateOct 23, 2019
Priority dateOct 24, 2018
Publication dateMar 19, 2024
Grant dateMar 19, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a functional wound dressing being able to provide substances supporting the healing of a wound to the wound depending on the condition of the wound. In particular, in case of an infection which is reported to be frequently associated with poorly healing wounds, such as chronic wounds, a therapeutic substance is provided to the wound whereas in other cases no therapeutic substance is provided. The present wound dressing can be used in moist wound healing and contains a substance being able to absorb wound exudate from the wound and to provide moisture to the wound.

First claim

Opening claim text (preview).

The invention claimed is: 1. A wound dressing comprising a) a hydrogel layer able to be orientated facing towards the wound, b) a layer comprising a pH-sensitive polymer, and c) one or more compartment(s) comprising carrier containing one or more therapeutic substance(s), wherein each compartment c) is placed in layer b), and wherein layer b) comprises one or more recesses opposite the wound, wherein in said one or more recesses the one or more compartment(s) c) are embedded. 2. The wound dressing according to claim 1 , wherein the hydrogel is a polyurethane-based hydrogel. 3. The wound dressing according to claim 1 , wherein the solubility of the pH-sensitive polymer at a pH value of 4 is less than at a pH value of 8. 4. The wound dressing according to claim 1 , wherein the solubility of the pH-sensitive polymer at 20° C. in an aqueous solution at a pH of 6 is less than 0.1 mg/min/g. 5. The wound dressing according to claim 4 , wherein the solubility of the pH-sensitive polymer at 20° C. in an aqueous solution at a pH of 8 is more than 1 mg/min/g. 6. The wound dressing according to claim 1 , wherein the solubility of the pH-sensitive polymer at 20° C. in an aqueous solution at a pH of 8 is more than 1 mg/min/g. 7. The wound dressing according to claim 1 , wherein the pH-sensitive polymer is a (methyl acrylate-methyl methacrylate-methacrylic acid) copolymer. 8. The wound dressing according to claim 1 , wherein layer b) further comprises a plasticizer. 9. The wound dressing according to claim 1 , wherein the carrier is of the same material as the hydrogel or the pH-sensitive polymer. 10. The wound dressing according to claim 1 , wherein the carrier is a polymer selected from polyethylene glycol, polypropylene glycol, polyethylene-polypropylene glycol copolymer, polyvinyl alcohol, polyvinylpyrrolidone, methylcellulose, hydroxypropyl methylcellulose and mixtures thereof. 11. The wound dressing according to claim 1 , wherein the carrier is polyvinyl alcohol. 12. The wound dressing according to claim 1 , wherein the one or more therapeutic substance(s) is an antimicrobial substance. 13. The wound dressing according to claim 1 , wherein the one or more therapeutic substance(s) is norfloxacin, ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and/or moxifloxacin. 14. The wound dressing according to claim 1 , wherein the carrier further contains a fluorescent dye and/or buffer substances. 15. A method of treating a wound comprising the step of applying a wound dressing to the wound, wherein said wound dressing comprises: a) a hydrogel layer able to be orientated facing towards the wound, b) a layer comprising a pH-sensitive polymer, and c) one or more compartments comprising carrier containing one or more therapeutic substances, wherein each of the one or more compartments c) is placed in layer b), wherein layer b) comprises one or more recesses opposite the wound, wherein in said one or more recesses the one or more compartment(s) c) are embedded, and wherein the one or more therapeutic substances is provided to the wound.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11931477B2 cover?
The invention relates to a functional wound dressing being able to provide substances supporting the healing of a wound to the wound depending on the condition of the wound. In particular, in case of an infection which is reported to be frequently associated with poorly healing wounds, such as chronic wounds, a therapeutic substance is provided to the wound whereas in other cases no therapeutic…
Who is the assignee on this patent?
Hartmann Paul Ag
What technology area does this patent fall under?
Primary CPC classification A61L26/008. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).